Atossa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.About ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C.
CEOSteven C. Quay
CEOSteven C. Quay
Employees15
Employees15
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2008
Founded2008
Employees15
Employees15
ATOS Key Statistics
Market cap101.27M
Market cap101.27M
Price-Earnings ratio-3.33
Price-Earnings ratio-3.33
Dividend yield—
Dividend yield—
Average volume533.77K
Average volume533.77K
High today$0.7832
High today$0.7832
Low today$0.7437
Low today$0.7437
Open price$0.7533
Open price$0.7533
Volume595.33K
Volume595.33K
52 Week high$1.36
52 Week high$1.36
52 Week low$0.5526
52 Week low$0.5526
Stock Snapshot
As of today, Atossa Therapeutics(ATOS) shares are valued at $0.78. The company's market cap stands at 101.27M, with a P/E ratio of -3.33.
On 2025-11-23, Atossa Therapeutics(ATOS) stock moved within a range of $0.74 to $0.78. With shares now at $0.78, the stock is trading +5.3% above its intraday low and -0.0% below the session's peak.
Trading volume for Atossa Therapeutics(ATOS) stock has reached 595.33K, versus its average volume of 533.77K.
Over the past 52 weeks, Atossa Therapeutics(ATOS) stock has traded between a high of $1.36 and a low of $0.55.
Over the past 52 weeks, Atossa Therapeutics(ATOS) stock has traded between a high of $1.36 and a low of $0.55.
People also own
Based on the portfolios of people who own ATOS. This list is generated using Robinhood data, and it’s not a recommendation.